| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.081 | 25.617 | 11.135 | 13.999 | 10.447 | 7.332 | 8.099 | 10.933 | 19.199 |
| Total Income - EUR | - | 20.081 | 25.617 | 18.142 | 20.785 | 10.616 | 7.339 | 8.237 | 31.389 | 19.205 |
| Total Expenses - EUR | - | 4.527 | 8.151 | 12.795 | 9.498 | 4.456 | 5.823 | 5.843 | 41.404 | 23.010 |
| Gross Profit/Loss - EUR | - | 15.553 | 17.466 | 5.347 | 11.286 | 6.160 | 1.516 | 2.394 | -10.016 | -3.805 |
| Net Profit/Loss - EUR | - | 14.951 | 16.698 | 4.803 | 10.663 | 5.871 | 1.320 | 2.175 | -10.016 | -3.805 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Intermed Asig-Imob Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 13.947 | 9.577 | 7.871 | 0 | 9.761 | 117.893 | 238.162 | 253.227 | 244.950 |
| Current Assets | - | 2.399 | 18.106 | 15.287 | 31.152 | 32.909 | 4.677 | 8.442 | 8.910 | 9.731 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 679 | 2.517 |
| Receivables | - | 0 | 10.945 | 60 | 4.738 | 2.345 | 894 | 485 | 6.384 | 6.036 |
| Cash | - | 2.399 | 7.161 | 15.227 | 26.414 | 30.564 | 3.783 | 7.957 | 1.847 | 1.179 |
| Shareholders Funds | - | 14.996 | 18.524 | 22.987 | 30.992 | 34.105 | 34.668 | 36.951 | 26.823 | 22.868 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.426 | 9.232 | 171 | 205 | 8.600 | 87.902 | 209.654 | 235.314 | 231.813 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6622 - 6622" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Intermed Asig-Imob Srl